The Well is Northwell Healths commitment to the future of health care
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
Lofton, M.D., director of the medical weight management program at NYU Langone Health and a member of HealthyWomens Womens Health Advisory Council, Some patients may find they are super responders to [the] recommended doses and can notice weight loss and other benefits when microdosing. But, theres not much research to back up the benefits of microdosing, and for that reason, professional organizations such as the American Diabetes Association do not endorse microdosing
Always consult with a healthcare provider for personalized medical advice
Lancet (London, England), 400(10366), 18691881.
This has engendered a degree of mistrust by clinicians.we have an 18-year track record of clinical safety with GLP-1 drugs